IQVIA Holdings vs BeOne Medicines

IQVIA Holdings (IQV), health care, and BeOne Medicines (ONC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

BeOne Medicines is worth $47.2B on the stock market and IQVIA Holdings $42.5B: BeOne Medicines is valued at 11% more. IQVIA Holdings trades at 31.3 times earnings and BeOne Medicines at 53.0; operating margins in their latest fiscal years were 13.4% and 8.37%. Over the past year IQVIA Holdings's share price has moved +21.8% and BeOne Medicines's +13.0%.

Key facts

IQVIA Holdings market value
$42.5B
BeOne Medicines market value
$47.2B
IQVIA Holdings P/E
31.3
BeOne Medicines P/E
53.0
IQVIA Holdings revenue
$16.3BFY to 2025-12-31
BeOne Medicines revenue
$5.3BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

IQVIA Holdings vs BeOne Medicines: every measure side by side
Measure IQVIA Holdings BeOne Medicines
SectorHealth CareHealth Care
Country United States Switzerland
Fiscal year ends2025-12-312025-12-31
Size
Market cap$42.5Blower$47.2Bhigher
Revenue$16.3Bhigher$5.3Blower
Earnings$1.4Bhigher$286.9Mlower
Employees95,000higher12,000lower
Total assets$29.9Bhigher$8.2Blower
Valuation
P/E31.3lower53.0higher
P/S2.6lower8.8higher
P/B6.4—
Dividend yield0.00%—
Profitability
Operating margin13.4%higher8.37%lower
Balance sheet
Net assets$6.5Bhigher$4.4Blower
Total liabilities$23.3Bhigher$3.8Blower
Total debt$15.7Bhigher$1Blower
Cash on hand$2Blower$4.5Bhigher
Price change
Today-2.69%lower+0.48%higher
1 year+21.8%higher+13.0%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio. Who owns IQV · Who owns ONC

Further comparisons

Learn

Questions and answers

Which is bigger, IQVIA Holdings or BeOne Medicines?

By market value, BeOne Medicines is the larger: $47.2B against $42.5B for IQVIA Holdings. By revenue in its latest fiscal year, IQVIA Holdings is the larger: $16.3B against $5.3B for BeOne Medicines.

Which has the higher P/E ratio?

BeOne Medicines: 53.0, against 31.3 for IQVIA Holdings. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

Which has the higher operating margin?

IQVIA Holdings: 13.4%, against 8.37% for BeOne Medicines. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

IQVIA Holdings: $15.7B, against $1B for BeOne Medicines. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both IQVIA Holdings and BeOne Medicines?

None of the tracked superinvestors holds both in their latest 13F filing. 8 hold IQVIA Holdings and 6 hold BeOne Medicines.

Cite this page

Funkfolio, “IQVIA Holdings vs BeOne Medicines”, data as of 18 November 2026. https://funkfolio.com/compare/iqv-vs-onc

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.